Phosphorylation events during viral infections provide potential therapeutic targets

Reviews in Medical Virology

Volumn 22, Issue 3, 2012, Pages 166-181

  Keating, Julie A ^b   Striker, Rob ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BENZIMIDAVIR; BENZIMIDAZOLE DERIVATIVE; CIDOFOVIR; EVEROLIMUS; GANCICLOVIR; MITOGEN ACTIVATED PROTEIN KINASE; NONSTRUCTURAL PROTEIN 5A; NUCLEOSIDE DERIVATIVE; RAPAMYCIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; VALGANCICLOVIR; VIRUS ENZYME; VIRUS PROTEIN;

ADENOVIRUS; APHTHOVIRUS; BONE MARROW SUPPRESSION; CYTOMEGALOVIRUS; DRUG TOLERABILITY; EBOLA HEMORRHAGIC FEVER; ENCEPHALOMYOCARDITIS VIRUS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GRAFT REJECTION; HEPATITIS E; HERPES VIRUS INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A; MEASLES VIRUS; MOLECULAR RECOGNITION; NEPHROTOXICITY; NONHUMAN; PARAINFLUENZA VIRUS 1; PHENOTYPE; PREDICTION; PROTEIN PHOSPHORYLATION; RABIES VIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RUBELLA VIRUS; SARS CORONAVIRUS; SEMLIKI FOREST ALPHAVIRUS; SIGNAL TRANSDUCTION; SINDBIS VIRUS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VACCINIA VIRUS; VARICELLA ZOSTER VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; WART VIRUS; WILD TYPE;

ANIMALS; HUMANS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; VIRAL PROTEINS; VIRUS DISEASES; VIRUSES;

EID: 84860256605     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.722     Document Type: Review

References (201)

1. Jakubiec A, Jupin I. Regulation of positive-strand RNA virus replication: the emerging role of phosphorylation. Virus Research 2007; 129(2): 73-79.
2. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298(5600): 1912-1934.
3. Jacob T, Van den Broeke C, Favoreel HW. Viral serine/threonine protein kinases. Journal of Virology 2011; 85(3): 1158-1173.
4. Toschi E, Bacigalupo I, Strippoli R, et al. HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway. Molecular Biology of the Cell 2006; 17(4): 1985-1994.
5. Herbein G, Gras G, Khan KA, Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology 2010; 7: 34-46.
6. Brinkmann MM, Schulz TF. Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae. The Journal of General Virology 2006; 87(5): 1047-1074.
7. Cheeran MC, Hu S, Sheng WS, Rashid A, Peterson PK, Lokensgard JR. Differential responses of human brain cells to West Nile virus infection. Journal of Neurovirology 2005; 11(6): 512-24.
8. Dawson CW, Tramountanis G, Eliopoulis AG, Young LS. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. The Journal of Biological Chemistry 2003; 278(6): 3694-3704.
9. Lee JY, Lucas WJ. Phosphorylation of viral movement proteins - regulation of cell-to-cell trafficking. Trends in Microbiology 2001; 9(1): 5-8.
10. Tyulkina LG, Karger EM, Sheveleva AA, Atabekov JG. Binding of monoclonal antibodies to the movement protein (MP) of Tobacco mosaic virus: influence of subcellular MP localization and phosphorylation. The Journal of General Virology 2010; 91(6): 1621-1628.
11. Muller B, Patschinsky T, Krausslich HG. The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles. Journal of Virology 2002; 76(3): 1015-1024.
12. Hemonnot B, Cartier C, Gay B, et al. The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the p6gag protein of HIV-1. The Journal of Biological Chemistry 2004; 279(31): 32426-32434.
13. Mal A, Piotrkowski A, Harter ML. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes. Journal of Virology 1996; 70(5): 2911-2921.
14. Meggio F, D'Agostino DM, Ciminale V, Chieco-Bianchi L, Pinna LA. Phosphorylation of HIV-1 Rev protein: implication of protein kinase CK2 and pro-directed kinases. Biochemical and Biophysical Research Communications 1996; 226(2): 547-554.
15. Quintavalle M, Sambucini S, Summa V, et al. Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors. The Journal of Biological Chemistry 2007; 232(8): 5536-5544.
16. Tellinghuisen TL, Foss KL, Treadaway J. Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathogens 2008; 4(3): e1000032.
17. Reeves PM, Bommarius B, Lebeis S, et al. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nature Medicine 2005; 11(7): 731-739.
18. McNulty S, Bornmann W, Schriewer J, et al. Multiple phosphatidylinositol 3-kinases regulate vaccinia virus morphogenesis. PLoS One 2010; 5(5): e10884.
19. Reeves PM, Smith SK, Olson VA, et al. Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on Abl and Src family tyrosine kinases. Journal of Virology 2011; 85(1): 21-31.
20. Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathogens 2008; 4(8): e1000141.
21. Newsome TP, Weisswange I, Frischknecht F, Way M. Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus. Cellular Microbiology 2006; 8(2): 233-241.
22. Law LM, Everitt JC, Beatch MD, Holmes CF, Hobman TC. Phosphorylation of rubella virus capsid regulates its RNA binding activity and virus replication. Journal of Virology 2003; 77(3): 1764-1771.
23. Law LJ, Ilkow CS, Tzeng WP, et al. Analyses of phosphorylation events in the rubella virus capsid protein: role in early replication events. Journal of Virology 2006; 80(14): 6917-6925.
24. Levinson AD, Oppermann H, Levintow L, Varmus HE, Bishop JM. Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein. Cell 1978; 15(2): 561-572.
25. Levinson AD, Oppermann H, Varmus HE, Bishop JM. The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine. The Journal of Biological Chemistry 1980; 255(24): 11973-11980.
26. Derrien M, Punjabi A, Khanna M, Grubisha O, Traktman P. Tyrosine phosphorylation of A17 during vaccinia virus infection: involvement of the H1 phosphatase and the F10 kinase. Journal of Virology 1999; 73(9): 7287-7296.
27. Nichols RJ, Wiebe MS, Traktman P. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Molecular Biology of the Cell 2006; 17(5): 2451-2464.
28. Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 2008; 320(5877): 797-799.
29. Cano-Monreal GL, Wylie KM, Cao F, Tavis JE, Morrison LA. Herpes simplex virus 2 UL13 protein kinase disrupts nuclear lamins. Virology 2009; 392(1): 137-147.
30. Kawaguchi Y, Kato K. Protein kinases conserved in herpesviruses potentially share a function mimicking the cellular protein kinase cdc2. Reviews in Medical Virology 2003; 13(5): 331-340.
31. Asai R, Kato A, Kato K, et al. Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1. Journal of Virology 2006; 80(11): 5125-5134.
32. Chen MR, Chang SJ, Huang H, Chen JY. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. Journal of Virology 2000; 74(7): 3093-3104.
33. Kato K, Yokoyama A, Tohya Y, Akashi H, Nishiyama Y, Kawaguchi Y. Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. The Journal of General Virology 2003; 84(12): 3381-3392.
34. Yue W, Gershburg E, Pagano JS. Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter. Journal of Virology 2005; 79(9): 5880-5885.
35. Yue W, Davenport MG, Shackelford J, Pagano JS. Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function. Journal of Virology 2004; 78(7): 3542-3552.
36. Wang ZX, Wu JW. Autophosphorylation kinetics of protein kinases. Biochemical Journal 2002; 368(3): 947-952.
37. Pickin KA, Chaudhury S, Dancy BC, Gray JJ, Cole PA. Analysis of protein kinase autophosphorylation using expressed protein ligation and computational modeling. Journal of the American Chemical Society 2008; 130(17): 5667-5669.
38. Smith JA, Francis SH, Walsh KA, Kumar S, Corbin JD. Autophosphorylation of type Ib cGMP-dependent protein kinase increases basal catalytic activity and enhances allosteric activation by cGMP or cAMP. The Journal of Biological Chemistry 1996; 271(34): 20756-20762.
39. Piwnica-Worms H, Saunders KB, Roberts TM, Smith AE, Cheng SH. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 1987; 49(1): 75-82.
40. Huang B, Chua LL, Bose N, Cai M. Negative regulation of the actin-regulating kinase Prk1p by patch localization-induced autophosphorylation. Traffic 2009; 10(1): 35-41.
41. Chu DM, Francis SH, Thomas JW, Maksymovitch EA, Fosler M, Corbin JD. Activation by autophosphorylation or cGMP binding produces a similar apparent conformational chance in cGMP-dependent protein kinase. The Journal of Biological Chemistry 1998; 273(23): 14649-14656.
42. Songyang Z, Shoelson SE, Chaudhuri M, et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993; 72(5): 767-778.
43. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annual Reviews in Cell and Developmental Biology 1997; 13: 513-609.
44. Pawson T. Protein modules and signalling networks. Nature 1995; 373(6515): 573-580.
45. Blackhall J, Fuentes A, Hansen K, Magnusson G. Serine protein kinase activity associated with rotavirus phosphoprotein NSP5. Journal of Virology 1997; 71(1): 138-144.
46. He Z, He YS, Kim Y, et al. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. Journal of Virology 1997; 71(1): 405-411.
47. Kato K, Kawaguchi Y, Tanaka M, et al. Epstein-Barr virus-encoded protein kinase BGLF4 mediates hyperphosphorylation of cellular elongation factor 1delta (EF-1delta): EF-1delta is universally modified by conserved protein kinases of herpesviruses in mammalian cells. The Journal of General Virology 2001; 82(6): 1457-1463.
48. Cunningham C, Davison AJ, Dolan A, et al. The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. The Journal of General Virology 1992; 73(2): 303-311.
49. Michel D, Mertens T. The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host. Biochimica et Biophysica Acta 2004; 1697(1-2): 169-180.
50. Cross FR, Hanafusa H. Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation. Cell 1983; 34(2): 597-607.
51. Blom N, Sicheritz-Ponten T, Gupta R, Gammeltoft S, Brunak S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 2004; 4(6): 1633-1649.
52. Obenauer JC, Cantley LC, Yaffe MB. Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Research 2003; 31(13): 3635-3641.
53. Ackermann MA, Kontrogianni-Konstantopoulos A. Myosin binding protein C slow is a novel substrate for protein kinase A (PKA) and C (PKC) in skeletal muscle. Journal of Proteome Research 2011; 10(10): 4547-4555.
54. Vagnoni A, Rodriguez L, Manser C, De Vos KJ, Miller CC. Phosphorylation of kinesin light chain 1 at serine 460 modulates binding and trafficking of calsyntenin-1. Journal of Cell Science 2011; 124(7): 1032-1042.
55. Balan V, Nangia-Makker P, Jung YS, Wang Y, Raz A. Galectin-3: a novel substrate for c-Abl kinase. Biochimica et Biophysica Acta 2010; 1803(10): 1198-1205.
56. Gross SD, Anderson RA. Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family. Cellular Signaling 1998; 10(10): 699-711.
57. Flotow H, Roach PJ. Role of acidic residues as substrate determinants for casein kinase I. The Journal of Biological Chemistry 1991; 266(6): 3724-3727.
58. Knippschild U, Gocht A, Wolff S, Huber N, Lohler J, Stoter M. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cellular Signaling 2005; 17(6): 675-689.
59. Eichwald C, Jacob G, Muszynski B, Allende JE, Burrone OR. Uncoupling substrate and activation functions of rotavirus NSP5: phosphorylation of Ser-67 by casein kinase 1 is essential for hyperphosphorylation. Proceedings of the National Academy of Sciences of the United States of America 2004; 101(46): 16304-16309.
60. Bhattacharya D, Mayuri, Best SM, Perera R, Kuhn RJ, Striker R. Protein kinase G phosphorylates mosquito-borne flavivirus NS5. Journal of Virology 2009; 83(18): 9195-9205.
61. Keating JA, Bhattacharya D, Lim PY, Bernard KA, Striker R. The methyltransferase domain is the major substrate for protein kinase G (PKG) phosphorylation of mosquito-borne flaviviral NS5. Paper presented at American Society for Virology: 30th Annual Meeting Scientific Program and Abstracts. Jul 16-20 2011; Minneapolis, MN.
62. Schlossmann J, Hofmann F. cGMP-dependent protein kinases in drug discovery. Drug Discovery Today 2005; 10(9): 627-634.
63. Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H, Cantley LC. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Current Biology 1994; 4(11): 973-982.
64. Dunn JD, Reid GE, Bruening ML. Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry. Mass Spectrometry Reviews 2010; 29(1): 29-54.
65. Yan JX, Packer NH, Gooley AA, Williams KL. Protein phosphorylation: technologies for the identification of phosphoamino acids. Journal of Chromatography. A 1998; 808: 23-41.
66. Mann M, Ong SE, Gronborg M, Steen H, Jensen ON, Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends in Biotechnology 2002; 20(6): 261-268.
67. Fyfe JA, Keller PM, Furman PA, Miller RL, Elion GB. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. The Journal of Biological Chemistry 1978; 253(24): 8721-8727.
68. Bird LE, Ren J, Wright A, et al. Crystal structure of varicella zoster virus thymidine kinase. The Journal of Biological Chemistry 2003; 278(27): 24680-24687.
69. Littler E, Stuart AD, Chee MS. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 1992; 358(6382): 160-162.
70. Crumpacker CS. Ganciclovir. The New England Journal of Medicine 1996; 335(10): 721-729.
71. Piret J, Boivin G. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrobial Agents and Chemotherapy 2011; 55(2): 459-472.
72. Miller WH, Miller RL. Phosphorylation of acyclovir (acycloguanosine) monophosphate by GMP kinase. The Journal of Biological Chemistry 1980; 255(15): 7204-7207.
73. Reardon JE, Spector T. Herpes simplex virus type 1 DNA polymerase. Mechanism of inhibition by acyclovir triphosphate. The Journal of Biological Chemistry 1989; 264(13): 7405-7411.
74. Cheng YC, Grill SP, Dutschman GE, Nakayama K, Bastow KF. Metabolism of 9-(1, 3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex virus-infected cells. The Journal of Biological Chemistry 1983; 258(20): 12460-12464.
75. Lurain NS, Chou S. Antiviral drug resistance of human cytomegalovirus. Clinical Microbiology Reviews 2010; 23(4): 689-712.
76. DeClercq E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clinical Microbiology Reviews 2003; 16(4): 569-596.
77. DeClercq E. Antiviral drugs in current clinical use. Journal of Clinical Virology 2004; 30(2): 115-133.
78. Field AK, Davies ME, DeWitt C, et al. 9-([2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication. Proceedings of the National Academy of Sciences of the United States of America 1983; 80(13): 4139-4143.
79. Sauerbrei A, Deinhardt S, Zell R, Wutzler P. Testing of herpes simplex virus for resistance to antiviral drugs. Virulence 2010; 1(6): 555-557.
80. Lurain NS, Thompson KD, Holmes EW, Read GS. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. Journal of Virology 1992; 66(12): 7146-7152.
81. Sullivan V, Biron KK, Talarico C, et al. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicrobial Agents and Chemotherapy 1993; 37(1): 19-25.
82. Collins P, Larder BA, Oliver NM, Kemp S, Smith IW, Darby G. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. The Journal of General Virology 1989; 70(2): 375-382.
83. Krosky PM, Baek MC, Coen DM. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. Journal of Virology 2003; 77(2): 905-914.
84. Biron KK, Harvey RJ, Chamberlain SC, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action. Antimicrobial Agents and Chemotherapy 2002; 46(8): 2365-2372.
85. Chou S, Wechel LC, Marousek GI. Cytomegalovirus UL97 kinase mutations that confer maribavir resistance. Journal of Infectious Diseases 2007; 196(1): 91-94.
86. Lalezari JP, Aberg JA, Wang LH, et al. Phase I dose escalation trial evaluating the pharmacokinetics, anti-human cytomegalovirus (HCMV) activity, and safety of 1263 W94 in human immunodeficiency virus-infected men with asymptomatic HCMV shedding. Antimicrobial Agents and Chemotherapy 2002; 46(9): 2969-2976.
87. Marty FM, Ljungman P, Papanicolaou GA, et al. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. The Lancet Infectious Diseases 2011; 11(4): 284-292.
88. Snydman DR. Why did maribavir fail in stem-cell transplants? The Lancet Infectious Diseases 2011; 11(4): 255-257.
89. Winston DJ, Young JA, Pullarkat V, et al. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood 2008; 111(11): 5403-5410.
90. Andrei G, DeClercq E, Snoeck R. Drug targets in cytomegalovirus infection. Infectious Disorders Drug Targets 2009; 9(2): 201-222.
91. Newsome TP, Scaplehorn N, Way M. SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science 2004; 306(5693): 124-129.
92. Frischknecht F, Moreau V, Rottger S, et al. Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 1999; 401(6756): 926-929.
93. Smith GL, Vanderplasschen A, Law M. The formation and function of extracellular enveloped vaccinia virus. The Journal of General Virology 2002; 83(12): 2915-2931.
94. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. The New England Journal of Medicine 2001; 344(14): 1031-1037.
95. Druker BJ, Sawyers CL, Kantarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. The New England Journal of Medicine 2001; 344(14): 1038-1042.
96. Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. The New England Journal of Medicine 2007; 356(2): 125-134.
97. Mok TS, Wu YL, Thongprasert T, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. The New England Journal of Medicine 2009; 361(10): 947-957.
98. O'Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. The New England Journal of Medicine 2003; 348(11): 994-1004.
99. Wei G, Rafiyath S, Liu D. First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib. Journal of Hematology & Oncology 2010; 3: 47-56.
100. Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 2000; 289(5486): 1938-1942.
101. Tzahar E, Moyer JD, Waterman H, et al. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. The EMBO Journal 1998; 17(20): 5948-5963.
102. Langhammer S, Koban R, Yue C, Ellerbrok H. Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa). Antiviral Research 2011; 89(1): 64-70.
103. Mercer J, Knebel S, Schmidt FI, Crouse J, Burkard C, Helenius A. Vaccinia strains use distinct forms of macropinocytosis for host-cell entry. Proceedings of the National Academy of Sciences of the United States of America 2010; 107(20): 9346-9351.
104. Yang H, Kim SK, Kim M, et al. Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. The Journal of Clinical Investigation 2005; 115(2): 379-387.
105. Masters J, Hinek AA, Uddin S, et al. Poxvirus infection rapidly activates tyrosine kinase signal transduction. The Journal of Biological Chemistry 2001; 276(51): 48371-48375.
106. Ahmed CM, Dabelic R, Waiboci LW, Jager LD, Heron LL, Johnson HM. SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system. Journal of Virology 2009; 83(3): 1402-1415.
107. Okimoto RA, Van Etten RA. Navigating the road toward optimal initial therapy for chronic myeloid leukemia. Current Opinion in Hematology 2011; 18(2): 89-97.
108. Gridelli C, De Marinis F, Di Maio M, Cortinovis D, Cappuzzo F, Mok T. Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: review of the evidence. Lung Cancer 2011; 71(3): 249-257.
109. Bray M, Martinez M, Smee DF, Kefauver D, Thompson E, Huggins JW. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus. Journal of Infectious Diseases 2000; 181(1): 10-19.
110. Stallone G, Schena A, Infante B, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. The New England Journal of Medicine 2005; 352(13): 1317-1323.
111. Campistol JM, Gutierrez-Dalmau A, Torregrosa JV. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 2004; 77(5): 760-762.
112. Stallone G, Infante B, Grandaliano G, Schena FP, Gesualdo L. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transplant International 2008; 21(9): 825-832.
113. Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology 2011; 140(5): 1410-1426.
114. Gold KA, Lee HY, Kim ES. Targeted therapies in squamous cell carcinoma of the head and neck. Cancer 2009; 115(5): 922-935.
115. Bhuvanakantham R, Cheong YK, Ng ML. West Nile virus capsid protein interaction with importin and HDM2 protein is regulated by protein kinase C-mediated phosphorylation. Microbes and Infection 2010; 12(8-9): 615-625.
116. Forwood JK, Brooks A, Briggs LJ, Xiao CY, Jans DA, Vasudevan SG. The 37-amino-acid interdomain of dengue virus NS5 protein contains a functional NLS and inhibitory CK2 site. Biochemical and Biophysical Research Communications 1999; 257(3): 731-737.
117. Bhattacharya D, Ansari IH, Striker R. The flaviviral methyltransferase is a substrate of Casein Kinase 1. Virus Research 2009; 141(1): 101-104.
118. Morozova OV, Tsekhanovskaya NA, Maksimova TG, Bachvalova VN, Matveeva Va, Kit YY. Phosphorylation of tick-borne encephalitis virus NS5 protein. Virus Research 1997; 49(1): 9-15.
119. Shih CM, Chen CM, Chen SY, Lee YH. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. Journal of Virology 1995; 69(2): 1160-1171.
120. Ide Y, Tanimoto A, Sasaguri Y, Padmanabhan R. Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-alpha catalytic subunit. Gene 1997; 201(1-2): 151-158.
121. Kim J, Lee D, Choe J. Hepatitis C virus NS5A protein is phosphorylated by casein kinase II. Biochemical and Biophysical Research Communications 1999; 257(3): 777-781.
122. Franck N, Le Seyec J, Guguen-Guillouzo C, Erdtmann L. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. Journal of Virology 2005; 79(5): 2700-2708.
123. Kim SJ, Kim JH, Kim YG, Lim HS, Oh JW. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation. The Journal of Biological Chemistry 2004; 279(48): 50031-50041.
124. Chen YC, Su WC, Huang JY, et al. Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A. Journal of Virology 2010; 84(16): 7983-7993.
125. Coito C, Diamond D, Neddermann P, Korth MJ, Katze MG. High-throughput screening of the yeast kinome: identification of human serine/threonine protein kinases that phosphorylated the hepatitis C virus NS5A protein. Journal of Virology 2004; 78(7): 3502-3513.
126. Surjit M, Kumar R, Mishra RN, Reddy MK, Chow VT, Lal SK. The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation. Journal of Virology 2005; 79(17): 11476-11486.
127. Peng TY, Lee KR, Tarn WY. Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization. FEBS Journal 2008; 275(16): 4152-4163.
128. Wu CH, Yeh SH, Tsay YG, et al. Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication. The Journal of Biological Chemistry 2009; 284(8): 5229-5239.
129. Li GP, La Starza MW, Hardy WR, Strauss JH, Rice CM. Phosphorylation of Sindbis virus nsP3 in vivo and in vitro. Virology 1990; 179(1): 416-427.
130. Liu N, Brown DT. Phosphorylation and dephosphorylation events play critical roles in Sindbis virus maturation. Virology 1993; 196(2): 703-711.
131. Peranen J, Takkinen K, Kalkkinen N, Kaariainen L. Semliki Forest virus-specific non-structural protein nsP3 is a phosphoprotein. The Journal of General Virology 1988; 69(9): 2165-2178.
132. La Torre JL, Grubman MJ, Baxt B, Bachrach HL. The structural polypeptides of aphthovirus are phosphoproteins. Proceedings of the National Academy of Sciences of the United States of America 1980; 77(12): 7444-7447.
133. Dvorak CM, Hall DJ, Hill M, et al. Leader protein of encephalomyocarditis virus binds zinc, is phosphorylated during viral infection, and affects the efficiency of genome translation. Virology 2001; 290(2): 261-271.
134. Zafrullah M, Ozdener MH, Panda SK, Jameel S. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. Journal of Virology 1997; 71(12): 9045-9053.
135. Barik S, Banerjee AK. Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proceedings of the National Academy of Sciences of the United States of America 1992; 89(14): 6570-6574.
136. Gupta AK, Das T, Banerjee AK. Casein kinase II is the P protein phosphorylating cellular kinase associated with the ribonucleoprotein complex of vesicular stomatitis virus. The Journal of General Virology 1995; 76(2): 365-372.
137. Gupta AK, Blondel D, Choudhary S, Banerjee AK. The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C. Journal of Virology 2000; 74(1): 91-98.
138. De BP, Gupta S, Gupta S, Banerjee AK. Cellular protein kinase C isoform zeta regulates human parainfluenza virus type 3 replication. Proceedings of the National Academy of Sciences of the United States of America 1995; 92(11): 5204-5208.
139. Sun D, Luthra P, Li Z, He B. PLK1 down-regulates parainfluenza virus 5 gene expression. PLoS Pathogens 2009; 5(7): e1000525.
140. Huntley CC, De BP, Banerjee AK. Phosphorylation of Sendai virus phosphoprotein by cellular protein kinase C zeta. The Journal of Biological Chemistry 1997; 272(26): 16578-16584.
141. Villanueva N, Navarro J, Mendez E, Garcia-Albert I. Identification of a protein kinase involved in the phosphorylation of the C-terminal region of human respiratory syncytial virus P protein. The Journal of General Virology 1994; 75(3): 555-565.
142. Dupuy LC, Dobson S, Bitko V, Barik S. Casein kinase 2-mediated phosphorylation of respiratory syncytial virus phosphoprotein P is essential for the transcription elongation activity of the viral polymerase; phosphorylation by casein kinase 1 occurs mainly at Ser215 and is without effect. Journal of Virology 1999; 73(10): 8384-8392.
143. Das T, Schuster A, Schneider-Schaulies S, Banerjee AK. Involvement of cellular casein kinase II in the phosphorylation of measles virus P protein: identification of phosphorylation sites. Virology 1995; 211(1): 218-226.
144. Ofir R, Weinstein Y, Bazarsky E, et al. Tyrosine phosphorylation of measles virus P-phosphoprotein in persistently infected neuroblastoma cells. Virus Genes 1996; 13(3): 203-210.
145. Reinhardt J, Wolff T. The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Veterinary Microbiology 2000; 74(1-2): 87-100.
146. Mahmoudian S, Auerochs S, Grone M, Marschall M. Influenza A virus proteins PB1 and NS1 are subject to functionally important phosphorylation by protein kinase C. The Journal of General Virology 2009; 90(6): 1392-1397.
147. Mitzner D, Dudek SE, Studtrucker N, et al. Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiology 2009; 11(10): 1502-1516.
148. Sanz-Ezquerro JJ, Fernandez Santaren J, Sierra T, et al. The PA influenza virus polymerase subunit is a phosphorylated protein. The Journal of General Virology 1998; 79(3): 471-478.
149. Modrof J, Muhlberger E, Klenk HD, Becker S. Phosphorylation of VP30 impairs ebola virus transcription. The Journal of Biological Chemistry 2002; 277(36): 33099-33104.
150. Loftering B, Muhlberger E, Tamura T, Klenk HD, Becker S. The nucleoprotein of Marburg virus is target for multiple cellular kinases. Virology 1999; 255(1): 50-62.
151. Modrof J, Moritz C, Kolesnikova L, et al. Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions. Virology 2001; 287(1): 171-182.
152. Eichwald C, Vascotto F, Fabbretti E, Burrone OR. Rotavirus NSP5: mapping phosphorylation sites and kinase activation and viroplasm localization domains. Journal of Virology 2002; 76(7): 3461-3470.
153. Ammosova T, Berro R, Jerebtsova M, et al. Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription. Retrovirology 2006; 3: 78-98.
154. Burnette B, Yu G, Felsted RL. Phosphorylation of HIV-1 gag proteins by protein kinase C. The Journal of Biological Chemistry 1993; 268(12): 8698-8703.
155. Coates K, Harris M. The human immunodeficiency virus type 1 Nef protein functions as a protein kinase C substrate in vitro. The Journal of General Virology 1995; 76(4): 837-844.
156. Firzlaff JM, Galloway DA, Eisenman RN, Luscher B. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. The New Biologist 1989; 1(1): 44-53.
157. Bell I, Martin A, Roberts S. The E1circumflexE4 protein of human papillomavirus interacts with the serine-arginine-specific protein kinase SRPK1. Journal of Virology 2007; 81(11): 5437-5448.
158. Gao Q, Kumar A, Srinivasan S, et al. PKN binds and phosphorylates human papillomavirus E6 oncoprotein. The Journal of Biological Chemistry 2000; 275(20): 14824-14830.
159. Grand RJ, Doorbar J, Smith KJ, Coneron I, Gallimore PH. Phosphorylation of the human papillomavirus type 1 E4 proteins in vivo and in vitro. Virology 1989; 170(1): 201-213.
160. Bryan JT, Han A, Fife KH, Brown DR. The human papillomavirus type 11 E1E4 protein is phosphorylated in genital epithelium. Virology 2000; 268(2): 430-439.
161. Armstrong DJ, Roman A. Human papillomavirus type 6 E7 protein is a substrate in vitro of protein kinase C. The Biochemical Journal 1995; 312(3): 667-670.
162. Liang YJ, Chang HS, Wang CY, Yu WC. DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues. The International Journal of Biochemistry & Cell Biology 2008; 40(11): 2431-2441.
163. Whalen SG, Marcellus RC, Barbeau D, Branton PE. Importance of the Ser-132 phosphorylation site in cell transformation and apoptosis by the adenovirus type 5 E1A protein. Journal of Virology 1996; 70(8): 5373-5383.
164. Whalen SG, Marcellus RC, Whalen A, Ahn NG, Ricciardi RP, Branton PE. Phosphorylation within the transactivation domain of adenovirus E1A protein by mitogen-activated protein kinase regulates expression of early region 4. Journal of Virology 1997; 71(5): 3545-3553.
165. Grose C, Jackson W, Traugh JA. Phosphorylation of varicella-zoster virus glycoprotein gpI by mammalian casein kinase II and casein kinase I. Journal of Virology 1989; 63(9): 3912-3918.
166. Habran L, Bontems S, Di Valentin E, Sadzot-Delvaux C, Piette J. Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity. The Journal of Biological Chemistry 2005; 280(32): 29135-29143.
167. Ng TI, Keenan L, Kinchington PR, Grose C. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. Journal of Virology 1994; 68(3): 1350-1359.
168. Kenyon TK, Lynch J, Hay J, Ruyechan W, Grose C. Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. Journal of Virology 2001; 75(18): 8854-8858.
169. Kenyon TK, Cohen JI, Grose C. Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane. Journal of Virology 2002; 76(21): 10980-10993.
170. Reddy SM, Cox E, Iofin I, Soong W, Cohen JI. Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. Journal of Virology 1998; 72(10): 8083-8088.
171. Kinchington PR, Fite K, Turse SE. Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation by the VZV open reading frame 66 protein. Journal of Virology 2000; 74(5): 2265-2277.
172. Eisfeld AJ, Turse SE, Jackson SA, Lerner EC, Kinchington PR. Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase. Journal of Virology 2006; 80(4): 1710-1723.
173. Morrison EE, Wang YF, Meredith DM. Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. Journal of Virology 1998; 72(9): 7108-7114.
174. Zhi Y, Sandri-Goldin RM. Analysis of the phosphorylation sites of herpes simplex virus type 1 regulatory protein ICP27. Journal of Virology 1999; 73(4): 3246-3257.
175. Elliott G, O'Reilly D, O'Hare P. Phosphorylation of the herpes simplex virus type 1 tegument protein VP22. Virology 1996; 226(1): 140-145.
176. Zahariadis G, Wagner MJ, Doepker RC, et al. Cell-type-specific tyrosine phosphorylation of the herpes simplex virus tegument protein VP11/12 encoded by gene UL46. Journal of Virology 2008; 82(13): 6098-6108.
177. Kato A, Yamamoto M, Ohno T, Kodaira H, Nishiyama Y, Kawaguchi Y. Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1. Journal of Virology 2005; 79(14): 9325-9331.
178. Kato A, Yamamoto M, Ohno T, et al. Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31. Journal of Virology 2006; 80(3): 1476-1486.
179. Ng TI, Ogle WO, Roizman B. UL13 protein kinase of herpes simplex virus 1 complexes with glycoprotein E and mediates the phosphorylation of the viral Fc receptor: glycoproteins E and I. Virology 1998; 241(1): 37-48.
180. Purves FC, Roizman B. The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22. Proceedings of the National Academy of Sciences of the United States of America 1992; 89(16): 7310-7314.
181. Ogle WO, Ng TI, Carter KL, Roizman B. The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0. Virology 1997; 235(2): 406-413.
182. Harel NY, Alwine JC. Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2. Journal of Virology 1998; 72(7): 5481-5492.
183. Barrasa MI, Harel NY, Alwine JC. The phosphorylation status of the serine-rich region of the human cytomegalovirus 86-kilodalton major immediate-early IE2/IEP86 affects temporal viral gene expression. Journal of Virology 2005; 79(3): 1428-1437.
184. Cook ID, Shanahan F, Farrell PJ. Epstein-Barr virus SM protein. Virology 1994; 205(1): 217-227.
185. Chi LM, Yu JS, Chang YS. Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1. Biochemical and Biophysical Research Communications 2002; 294(3): 586-591.
186. Yue W, Shackelford J, Pagano JS. cdc2/Cyclin B1-dependent phosphorylation of EBNA2 at Ser243 regulates its function in mitosis. Journal of Virology 2006; 80(4): 2045-2050.
187. Panousis CG, Rowe DT. Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. Journal of Virology 1997; 71(6): 4752-4760.
188. Scholle F, Longnecker R, Raab-Traub N. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for c-terminal Src kinase. Journal of Virology 1999; 73(6): 4767-4775.
189. Baumann M, Mischak H, Dammeier S, et al. Activation of the Epstein-Barr virus transcription factor (BZLF1) by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation. Journal of Virology 1998; 72(10): 8105-8114.
190. Burkhardt AL, Bolen JB, Kieff E, Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. Journal of Virology 1992; 66(8): 5161-6167.
191. Polson AG, Huang L, Lukac DM, et al. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. Journal of Virology 2001; 75(7): 3175-3184.
192. McCormick C, Ganem D. Phosphorylation and function of the kaposin B direct repeats of Kaposi's sarcoma-associated herpesvirus. Journal of Virology 2006; 80(12): 6165-6170.
193. Malik P, Clements JB. Protein kinase CK2 phosphorylation regulates the interaction of Kaposi's sarcoma-associated herpesvirus regulatory protein ORF57 with its multifunctional partner hnRNP K. Nucleic Acids Research 2004; 32(18): 5553-5569.
194. Park J, Lee D, Seo T, Chung J, Choe J. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) open reading frame 36 protein is a serine protein kinase The Journal of General Virology 2000; 81(4): 1067-1071.
195. Enomoto M, Sawano Y, Kosuge S, Yamano Y, Kuroki K, Ohtsuki K. High phosphorylation of HBV core protein by two alpha-type CK2-activated cAMP-dependent protein kinases in vitro. FEBS Letters 2006; 580(3): 894-899.
196. Kang HY, Lee S, Park SG, Yu J, Kim Y, Jung G. Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochemical Journal 2006; 398(2): 311-317.
197. Lee YI, Kim SO, Kwon HJ, Park JG, Song MJ, Jeong SS. Phosphorylation of purified recombinant hepatitis B virus-X protein by mitogen-activated protein kinase and protein kinase C in vitro. Journal of Virological Methods 2001; 95(1-2): 1-10.
198. Kang H, Yu J, Jung G. Phosphorylation of hepatitis B virus core C-terminally truncated protein (Cp149) by PKC increases capsid assembly and stability. Biochemical Journal 2008; 416(1): 47-54.
199. Noh EJ, Jung HJ, Jeong G, et al. Subcellular localization and transcriptional repressor activity of HBx on p21(WAF1/Cip1) promoter is regulated by ERK-mediated phosphorylation. Biochemical and Biophysical Research Communications 2004; 319(3): 738-745.
200. Daub H, Blencke S, Habenberger P, et al. Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. Journal of Virology 2002; 76(16): 8124-8137.
201. Duclos-Vallee JC, Capel F, Mabit H, Petit MA. Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity. The Journal of General Virology 1998; 79(7): 1665-1670.